Compare Cronos Group Inc (CRON) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Kinder Morgan Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Kinder Morgan Inc trades at $32.23 (market cap $71.81B). The key difference: Kinder Morgan Inc is far larger — about 60.9× Cronos Group Inc's market cap, and Kinder Morgan Inc pays a 3.66% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Kinder Morgan Inc for 150 Days on average.
| CRON | KMI | |
|---|---|---|
Market Cap | $1.18B | $71.81B |
Volume | 968,037 | 16,921,908 |
Sector | Health | Energy |
52-Week High | $3.55 | $34.31 |
52-Week Low | $2.30 | $25.84 |
Typical Hold Time | 22 Days | 150 Days |
Enterprise Value | $387.62M | $103.86B |
Dividend Yield | — | 3.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Kinder Morgan (KMI) trades at $31.82, down 1.06% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with revenue growth from $15.1B in 2024 to $16.9B in 2025 and net income margins expanding to 19.31%. Recent earnings beats in Q4 2025 through Q2 2026 highlight operational strength, while a $6B-$7B growth pipeline supports future expansion in natural gas infrastructure.
KMI presents a compelling investment case with analyst consensus target of $37.20 offering 17% upside potential. The stock's 4% dividend yield and consistent cash flow generation provide income stability, though exposure to energy market volatility and high debt levels ($29.66B long-term debt) remain key risks. Wall Street sentiment is balanced with 47% buy ratings versus 50% hold recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
